IONS•benzinga•
BMO Capital Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $45
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 20, 2025 by benzinga